Based on percent spliced in (PSI) values of KRAS E4 from the TCGA SpliceSeq database, we performed a comprehensive analysis of E4 inclusion rates across 33 TCGA cancer types (Figure 1C) (Ryan et al. 2016). This evidence concerns the gene KRAS and cancer.